$Alveolar nitric oxide in adults with asthma: evidence of distal lung inflammation in refractory asthma.$

Alveolar nitric oxide in adults with asthma: evidence of distal lung inflammation in refractory asthma.

Recent studies have suggested that alveolar nitric oxide (NO) concentration is a noninvasive test of distal lung inflammation. The current study determined whether alveolar NO concentration can be measured in patients with asthma of varying severity, tested the hypothesis that there is an associatio...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Berry, M, Hargadon, B, Morgan, A, Shelley, M, Richter, J, Shaw, D, Green, R, Brightling, C, Wardlaw, A, Pavord, I
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	2005

Παρόμοια τεκμήρια

Evidence of a role of tumor necrosis factor alpha in refractory asthma.
ανά: Berry, M, κ.ά.
Έκδοση: (2006)

Association between neutrophilic airway inflammation and airflow limitation in adults with asthma.
ανά: Shaw, D, κ.ά.
Έκδοση: (2007)

The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma.
ανά: Berry, M, κ.ά.
Έκδοση: (2005)

The significance of eosinophilic airway inflammation in asthma
ανά: Pavord, I, κ.ά.
Έκδοση: (2002)

Mepolizumab and exacerbations of refractory eosinophilic asthma.
ανά: Haldar, P, κ.ά.
Έκδοση: (2009)

The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial.
ανά: Shaw, D, κ.ά.
Έκδοση: (2007)

The role of oral methotrexate as a steroid sparing agent in refractory eosinophilic asthma.
ανά: Bilocca, D, κ.ά.
Έκδοση: (2017)

TNF-alpha in asthma.
ανά: Berry, M, κ.ά.
Έκδοση: (2007)

Body mass and fat mass in refractory asthma: an observational 1 year follow-up study.
ανά: Bafadhel, M, κ.ά.
Έκδοση: (2010)

New insights into the relationship between airway inflammation and asthma.
ανά: Wardlaw, A, κ.ά.
Έκδοση: (2002)

Cluster analysis and clinical asthma phenotypes.
ανά: Haldar, P, κ.ά.
Έκδοση: (2008)

Mepolizumab in refractory eosinophilic asthma.
ανά: Pavord, I, κ.ά.
Έκδοση: (2010)

Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma.
ανά: Berry, M, κ.ά.
Έκδοση: (2007)

Management of asthma in adults: current therapy and future directions.
ανά: Green, R, κ.ά.
Έκδοση: (2003)

Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.
ανά: Green, R, κ.ά.
Έκδοση: (2002)

Eosinophils in asthma and other allergic diseases.
ανά: Wardlaw, A, κ.ά.
Έκδοση: (2000)

Exacerbations of severe asthma in patients treated with mepolizumab
ανά: Shrimanker, R, κ.ά.
Έκδοση: (2018)

Cough and asthma.
ανά: Berry, M, κ.ά.
Έκδοση: (2003)

Non-eosinophilic corticosteroid unresponsive asthma.
ανά: Pavord, I, κ.ά.
Έκδοση: (1999)

The use of exhaled nitric oxide in the management of asthma.
ανά: Pavord, I, κ.ά.
Έκδοση: (2008)

Comparison of asthma treatment given in addition to inhaled corticosteroids on airway inflammation and responsiveness.
ανά: Green, R, κ.ά.
Έκδοση: (2006)

New insights into the role of the mast cell in asthma.
ανά: Brightling, C, κ.ά.
Έκδοση: (2003)

Antagonism of tumour necrosis factor alpha in refractory asthma.
ανά: Berry, M, κ.ά.
Έκδοση: (2008)

A cross-sectional study of patterns of airway dysfunction, symptoms and morbidity in primary care asthma.
ανά: Shaw, D, κ.ά.
Έκδοση: (2012)

CRTH2 expression on T cells in asthma.
ανά: Mutalithas, K, κ.ά.
Έκδοση: (2010)

Comparison of airway immunopathology of eosinophilic bronchitis and asthma.
ανά: Brightling, C, κ.ά.
Έκδοση: (2003)

Development of irreversible airflow obstruction in a patient with eosinophilic bronchitis without asthma.
ανά: Brightling, C, κ.ά.
Έκδοση: (1999)

Eosinophil protein in airway macrophages: a novel biomarker of eosinophilic inflammation in patients with asthma.
ανά: Kulkarni, N, κ.ά.
Έκδοση: (2010)

A comparison of the validity of different diagnostic tests in adults with asthma.
ανά: Hunter, C, κ.ά.
Έκδοση: (2002)

Biomarkers predicting response to corticosteroid therapy in asthma.
ανά: Brightling, C, κ.ά.
Έκδοση: (2005)

Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: A 12-month follow-up analysis
ανά: Haldar, P, κ.ά.
Έκδοση: (2014)

Mast-cell infiltration of airway smooth muscle in asthma.
ανά: Brightling, C, κ.ά.
Έκδοση: (2002)

The relationship between clinical outcomes and medication adherence in difficult-to-control asthma.
ανά: Murphy, A, κ.ά.
Έκδοση: (2012)

Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: A 12-month follow-up analysis
ανά: Haldar, P, κ.ά.
Έκδοση: (2014)

Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: a 12-month follow-up analysis.
ανά: Haldar, P, κ.ά.
Έκδοση: (2014)

Sputum and bronchial submucosal IL-13 expression in asthma and eosinophilic bronchitis.
ανά: Berry, M, κ.ά.
Έκδοση: (2004)

Increased sputum and bronchial biopsy IL-13 expression in severe asthma.
ανά: Saha, S, κ.ά.
Έκδοση: (2008)

IgE sensitization to Aspergillus fumigatus is associated with reduced lung function in asthma.
ανά: Fairs, A, κ.ά.
Έκδοση: (2010)

Eosinophils in asthma and airway hyperresponsiveness.
ανά: Brightling, C, κ.ά.
Έκδοση: (2004)

Exhaled nitric oxide and inhaled corticosteroid dose reduction in asthma: a cohort study.
ανά: Wilson, E, κ.ά.
Έκδοση: (2014)